Small molecule drug discovery
Breakthrough therapies for inflammatory disease and oncology
Who We Are:
- Orphagen is a pioneer in the screening, discovery and development of ligands that modulate orphan or unexplored members of the nuclear receptor family.
- We have proprietary leads for novel drug targets with potential applications in precision oncology and autoimmune disease.